Back
ARS Pharmaceuticals Vs. Avidity Biosciences Industry Stock Comparison
Sell
35
SPRY
ARS Pharmaceuticals
Last Price:
14.87
Seasonality Move:
-2.91%
Sell
31
RNA
Avidity Biosciences
Last Price:
45.67
Seasonality Move:
-1.3%
Sell
35
ARS Pharmaceuticals (SPRY)
is a Sell
Is ARS Pharmaceuticals a Buy, Sell or Hold?
- The current ARS Pharmaceuticals [SPRY] share price is $14.05. The Score for SPRY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- SPRY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $44.64. The Score for RNA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPRY Stock Price Chart
What is ARS Pharmaceuticals's stock price today?
-
The ARS Pharmaceuticals share price today is $14.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $44.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
SPRY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.35 | Buy |
Relative Strength Index (14 RSI): | 63.23 | Buy |
Chaikin Money Flow: | 629993 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.04 - 13.82) | Buy |
Bollinger Bands (100): | (8.53 - 12.15) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 58.78 | Buy |
Chaikin Money Flow: | 2358339 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.17 - 44.49) | Buy |
Bollinger Bands (100): | (30.01 - 45.23) | Buy |
SPRY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.65 | Buy |
20-day SMA: | 12.71 | Buy |
50-day SMA: | 11.83 | Buy |
200-day SMA: | 8.83 | Buy |
8-day EMA: | 12.95 | Buy |
20-day EMA: | 12.6 | Buy |
50-day EMA: | 11.79 | Buy |
200-day EMA: | 9.39 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.71 | Buy |
20-day SMA: | 42.36 | Buy |
50-day SMA: | 43.76 | Buy |
200-day SMA: | 26.77 | Buy |
8-day EMA: | 42.29 | Buy |
20-day EMA: | 42.39 | Buy |
50-day EMA: | 41.68 | Buy |
200-day EMA: | 30.34 | Buy |
ARS Pharmaceuticals Earnings Growth & SPRY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.26 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.
ARS Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |